Sayagcot, Normia M.

HRN: 05-85-46  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/23/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/23/2022
11/30/2022
IV
600 Mg
Q8H
Cellulitis
Waiting Final Action 
11/26/2022
CEFTRIAXONE 1G (VIAL)
11/26/2022
12/03/2022
IV
2g
OD
Cellulitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: